Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicinesVANCOUVER, British Columbia--(BUSINESS ...
Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End MarketsExpands Mechanical Services ...
Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage ...
SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition ...
Appoints R. Brent Jones CFOReaffirms 2026 OutlookNORTH BETHESDA, Md.--(BUSINESS WIRE)--$ESAB #ESAB--ESAB Corporation ("ESAB" or the "Company") (NYSE: ESAB), a focused premier industrial compounder, ...
New market-intelligence report finds post-acute providers are prioritizing practical technologies and managed services that ...
Affordable, cloud-based SaaS solution automates E2B (R2) to E2B (R3) conversion for small and mid-size pharma ...
Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient ...
Regulatory News:Celyad Oncology (Euronext: CYAD) (the “Company”), today announces its financial results for the fiscal year ...
POLAR is a randomized, double-blind, placebo-controlled study that enrolled 43 patients with PMM2-CDG across 15 sites ...
IND approval from the FDA allows CanWell Pharma to assess the safety, tolerability and pharmacokinetics of CAN016 in a Phase ...
GlyphAgo achieved therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results